glp 1 receptor agonists are contraindicated in Frontiers Understanding GLP-1 receptor agonists and

Abbreviations CSII, continuous subcutaneous insulin infusion

But they had limitations: short timelines, selective populations, and controlled conditions

Individuals who are losing weight may opt for healthier, low-calorie drink options or reduce their alcohol intake altogether

Publication: Canadian Journal of Physiology and Pharmacology 18 November 2025 Abstract Incretin-based therapies, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs), exert a wide range of beneficial effects beyond glycemic control, largely mediated by their anti-inflammatory properties

Led by Dr

Acknowledgments The authors gratefully acknowledge the critical reviews and insights of Sarah Armstrong MD, Nancie MacIver MD PhD, and Lisa Rasbach PhD CPNP